Tuesday, February 9, 2010
HomeEventsContact UsRegister OnlineSubscriber Log-In
 
Monthly Subscribers
Log In
Register for Online Account
Access Current Issue
Access Archived Issues
Access Special Reports
Customer Service
Renew Subscription
Contact Editors
Frequently Asked Questions
Biotech Investor
Free E-Newsletter
Recommended Reading
 

Sign-Up Today -- FREE Weekly Newsletter from Forbes/Gottlieb

The Biotech and Medical Device Insider

Biotech, more than any other sector, produces clear winners and losers. Some biotech companies are going to bring promising new drugs to market and their stock prices are going to enjoy significant gains. Other companies are going to have equally spectacular collapses in their clinical development programs, and their stocks will plunge proportionally.

Each week the new, Forbes/Gottlieb Biotech and Medical Device Insider will keep you up to date with this fast-changing world and provide the information and guidance to stay on top of these constantly changing sectors.

Our editor, Dr. Scott Gottlieb is not only a former Director at the FDA and a top official at the Medicare program, he is a physician and a former Wall Street analyst who worked for one of the leading investment banks.

Here's what you get in each FREE Weekly Newsletter:

  • From Washington and Wall Street: Review of a medical or biotech topic that could affect your investment portfolio.
  • Industry Perspectives: Scott's unique analysis on the week's biggest stories in the medical or biotech sector.
  • Don't Miss Articles: Recap of the week's breaking news articles and links to stories that every medical or biotech investor must have on their reading list.
  • Events to Watch: Preview of upcoming medical or biotech news and events.
  • Preview of Forbes / Gottlieb Biotech Investor: Get a sneak peek of premium content from the monthly report.

Biotech and Medical Device Insider Newsletter Sign-Up -- FREE!

Full Name
Address
City
State/Province
Zip
Country
Email Address
   Send me information via email about products published by Forbes.
 
Forbes/Gottlieb E-Newsletter Archive
 



Copyright 2005 Forbes/Gottlieb Biotech Investor. All rights reserved.